DEF 14A

Company

Tempest Therapeutics, Inc.

Filed

November 12, 2024

Period of Report

December 3, 2024

Accession Number

0001140361-24-046210

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →